MA56386A - Polythérapie comprenant de l'acétyl-leucine et du miglustat - Google Patents

Polythérapie comprenant de l'acétyl-leucine et du miglustat

Info

Publication number
MA56386A
MA56386A MA056386A MA56386A MA56386A MA 56386 A MA56386 A MA 56386A MA 056386 A MA056386 A MA 056386A MA 56386 A MA56386 A MA 56386A MA 56386 A MA56386 A MA 56386A
Authority
MA
Morocco
Prior art keywords
polytherapy
miglustat
leucine
including acetyl
acetyl
Prior art date
Application number
MA056386A
Other languages
English (en)
Inventor
Mallory Factor
Michael Strupp
Original Assignee
Intrabio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrabio Ltd filed Critical Intrabio Ltd
Publication of MA56386A publication Critical patent/MA56386A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA056386A 2019-06-28 2020-06-26 Polythérapie comprenant de l'acétyl-leucine et du miglustat MA56386A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962868383P 2019-06-28 2019-06-28
US201962931003P 2019-11-05 2019-11-05

Publications (1)

Publication Number Publication Date
MA56386A true MA56386A (fr) 2022-05-04

Family

ID=71452519

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056386A MA56386A (fr) 2019-06-28 2020-06-26 Polythérapie comprenant de l'acétyl-leucine et du miglustat

Country Status (4)

Country Link
US (1) US20220362189A1 (fr)
EP (1) EP3989962A1 (fr)
MA (1) MA56386A (fr)
WO (1) WO2020261230A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201709459D0 (en) 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine
MX2021006559A (es) * 2018-12-06 2021-08-16 Intrabio Ltd Analogos deuterados de acetil-leucina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2626514C2 (ru) 2010-06-25 2017-07-28 Шир Хьюман Дженетик Терапис, Инк. Доставка к цнс лечебных агентов
JP7393943B2 (ja) 2016-08-11 2023-12-07 イントラバイオ リミティド リソソーム蓄積障害に関する医薬組成物及び使用

Also Published As

Publication number Publication date
WO2020261230A1 (fr) 2020-12-30
EP3989962A1 (fr) 2022-05-04
US20220362189A1 (en) 2022-11-17

Similar Documents

Publication Publication Date Title
MA46716A (fr) Polythérapie de thérapie cellulaire et d'inhibiteur de la microglie
MA52924A (fr) Formulations topiques comprenant du montélukast et combinaisons avec protéines d'adhérence de moule
UA42295S (uk) Комп'ютер
FR3077309B1 (fr) Procede et kit de construction d'abri
UA42369S (uk) Комп'ютер
MA51708A (fr) Identification d'applications avec l'apprentissage machine
MA56386A (fr) Polythérapie comprenant de l'acétyl-leucine et du miglustat
DK3979827T3 (da) Næringssammensætning omfattende 2'fucosyllactose og 3'galactosyllactose
JP2021101083A5 (fr)
UA43289S (uk) 1, 2, 3, 4 - манекен жіночий; 5 - манекен дитячий
UA39605S (uk) Стілець учнівський
IT201900023589A1 (it) “Macchina e metodo per esercizio fisico”
ES1261716Y (es) "cubrecajas"
MA55793A (fr) Simulateur d'entraînement à l'intervention chirurgicale
UA36802S (uk) Стіл учнівський
JP2021101084A5 (fr)
TH187488S (th) ถังขยะ
MA54156A (fr) Compositions comprenant des herbicides de type carboxylate de pyridine et des phytoprotecteurs de type carboxylate d'azole
IT201800001753U1 (it) “corpo di bombetta da esercitazioni in acciaio ”
MA54152A (fr) Compositions phytoprotectrices comprenant des herbicides à base de carboxylate de pyridine et d'isoxadifène
IT201800009293A1 (it) "divano"
IT201700093280U1 (it) Dispositivo formatore di “taco”
UA40125S (uk) Молоток покрівельника
UA37627S (uk) Чоловіча сорочка
MA53667A (fr) Polythérapie associant un composé d'acylthiourée et de l'abiratérone